Maurizio Chiarenza
24 works · 1,096 citations · h-index 7
Top works
- A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
- Lung cancer screening with spiral CT
- Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
- Surgical Procedures in the DANTE Trial, A Randomized Study of Lung Cancer Early Detection with Spiral Computed Tomography: Comparative Analysis in the Screening and Control Arm
- Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma.
- Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer
- DANTE: A RANDOMIZED STUDY ON LUNG CANCER SCREENING WITH LOW-DOSE SPIRAL CT (LDCT): END OF ACCRUAL AND PRELIMINARY RESULTS
- Vinorelbine and Cisplatin for the Treatment of Recurrent and/or Metastatic Carcinoma of the Uterine Cervix
- Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
- After HERA trial: Safety and activity of trastuzumab plus chemotherapy as first-line therapy for patients with breast cancer previously treated with trastuzumab in adjuvant setting—A single-institution experience.
- Fulvestrant in metastatic breast cancer: Safety, efficacy, and role as mainteinance therapy for heavily pretreated patients
- 3-Month Triptorelin in Premenopausal Patients with Hormone Receptor-Positive Early Breast Cancer: A Commentary and a Retrospective Experience
- Neoadjuvant trastuzumab and sequential chemotherapy with cisplatin, vinorelbine, and docetaxel for stage II-III breast cancer patients: Final results of a single institution phase II study.
- Association of weekly gemcitabine to conformal radiotherapy as organ-sparing strategy in locally advanced or relapsed bladder cancer
- Use of trastuzumab associated with cisplatin and vinorelbine followed by docetaxel as a neoadjuvant regimen for patients with HER2-positive breast cancer.
- Adjuvant trastuzumab in the treatment of small HER2-positive tumors: A single institution experience.
- Salivary miRNA-210 involvement in medication-related osteonecrosis of the jaws.
- Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer
- Different outcomes of cardiologic safety of trastuzumab in adjuvant or metastatic setting in patients with breast cancer: A single institution experience.
- Book Reviews